Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.850
+0.170 (6.34%)
At close: Jun 15, 2026, 4:00 PM EDT
2.820
-0.030 (-1.05%)
After-hours: Jun 15, 2026, 7:56 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $854.71 million as of June 15, 2026. Its market cap has increased by 74.63% in one year.
Market Cap
854.71M
Enterprise Value
836.21M
1-Year Change
74.63%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $854.71M, a decrease of -35.50%. That is a compound annual growth rate of -7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 854.71M | -21.16% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cullinan Therapeutics | 841.98M |
| Arbutus Biopharma | 841.51M |
| Janux Therapeutics | 826.95M |
| Phathom Pharmaceuticals | 823.69M |
| Inventiva | 822.46M |
| LB Pharmaceuticals | 814.99M |
| Kura Oncology | 803.41M |
| Odyssey Therapeutics | 797.24M |